Answer
Spikevax LP.8.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in people aged 6 months and older, in accordance with official recommendations.
Sources for this answer
- Spikevax LP.8.1Moderna Biotech Distributor UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked